Aprogen Medicines Past Earnings Performance
Past criteria checks 0/6
Aprogen Medicines's earnings have been declining at an average annual rate of -30.7%, while the Machinery industry saw earnings growing at 18.4% annually. Revenues have been growing at an average rate of 9.9% per year.
Key information
-30.7%
Earnings growth rate
16.7%
EPS growth rate
| Machinery Industry Growth | 18.9% |
| Revenue growth rate | 9.9% |
| Return on equity | -23.3% |
| Net Margin | -36.9% |
| Last Earnings Update | 31 Dec 2023 |
Revenue & Expenses BreakdownBeta
How Aprogen Medicines makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 150,578 | -55,619 | 72,244 | 42,817 |
| 30 Sep 23 | 150,272 | -96,929 | 40,430 | 34,196 |
| 30 Jun 23 | 138,095 | -80,200 | 52,407 | 34,196 |
| 31 Mar 23 | 107,219 | -98,809 | 73,157 | 35,294 |
| 31 Dec 22 | 78,349 | -98,657 | 62,628 | 38,561 |
| 30 Sep 22 | 47,080 | -98,930 | 65,150 | 46,125 |
| 30 Jun 22 | 26,058 | -106,306 | 49,084 | 46,125 |
| 31 Mar 22 | 1,431 | -110,891 | 37,016 | 50,828 |
| 31 Dec 21 | 26,296 | -93,920 | 43,833 | 32,780 |
| 30 Sep 21 | 48,044 | -90,340 | 39,579 | 23,846 |
| 30 Jun 21 | 73,831 | -36,606 | 20,099 | 24,294 |
| 31 Mar 21 | 123,388 | -42,468 | 28,202 | 1,188 |
| 31 Dec 20 | 127,143 | -46,490 | 28,036 | 1,029 |
| 30 Sep 20 | 126,565 | -47,720 | 26,715 | 850 |
| 30 Jun 20 | 117,642 | -68,785 | 28,318 | 402 |
| 31 Mar 20 | 100,987 | -18,336 | 21,813 | 432 |
| 31 Dec 19 | 78,249 | -10,839 | 14,373 | 1,871 |
| 30 Sep 19 | 63,757 | -597 | 7,651 | 5,900 |
| 30 Jun 19 | 52,781 | -13,019 | 2,533 | 5,900 |
| 31 Mar 19 | 52,616 | -27,534 | 1,537 | 5,835 |
| 31 Dec 18 | 51,047 | -24,916 | 2,873 | 4,381 |
| 31 Dec 17 | 40,376 | 4,028 | 2,694 | 364 |
| 30 Sep 13 | 141,616 | 26,940 | 285 | 0 |
| 30 Jun 13 | 150,446 | -56,072 | 1,328 | 0 |
Quality Earnings: A007460 is currently unprofitable.
Growing Profit Margin: A007460 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A007460 is unprofitable, and losses have increased over the past 5 years at a rate of 30.7% per year.
Accelerating Growth: Unable to compare A007460's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A007460 is unprofitable, making it difficult to compare its past year earnings growth to the Machinery industry (11.5%).
Return on Equity
High ROE: A007460 has a negative Return on Equity (-23.29%), as it is currently unprofitable.